These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25728267)
21. Purification and separation of the 20S immunoproteasome from the constitutive proteasome and identification of the subunits by LC-MS. Dechavanne V; Vilbois F; Glez L; Antonsson B Protein Expr Purif; 2013 Feb; 87(2):100-10. PubMed ID: 23147206 [TBL] [Abstract][Full Text] [Related]
22. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes. Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729 [TBL] [Abstract][Full Text] [Related]
23. Interactions of the natural product kendomycin and the 20S proteasome. Beck P; Heinemeyer W; Späth AL; Elnakady Y; Müller R; Groll M J Mol Biol; 2014 Sep; 426(18):3108-3117. PubMed ID: 25038530 [TBL] [Abstract][Full Text] [Related]
24. Subunit architecture of intact protein complexes from mass spectrometry and homology modeling. Taverner T; Hernández H; Sharon M; Ruotolo BT; Matak-Vinković D; Devos D; Russell RB; Robinson CV Acc Chem Res; 2008 May; 41(5):617-27. PubMed ID: 18314965 [TBL] [Abstract][Full Text] [Related]
25. Identification of alpha-type subunits of the Xenopus 20S proteasome and analysis of their changes during the meiotic cell cycle. Wakata Y; Tokumoto M; Horiguchi R; Ishikawa K; Nagahama Y; Tokumoto T BMC Biochem; 2004 Dec; 5(1):18. PubMed ID: 15603592 [TBL] [Abstract][Full Text] [Related]
26. Structural Elucidation of a Nonpeptidic Inhibitor Specific for the Human Immunoproteasome. Cui H; Baur R; Le Chapelain C; Dubiella C; Heinemeyer W; Huber EM; Groll M Chembiochem; 2017 Mar; 18(6):523-526. PubMed ID: 28098422 [TBL] [Abstract][Full Text] [Related]
27. Bisbenzimidazole derivatives as potent inhibitors of the trypsin-like sites of the immunoproteasome core particle. Koroleva ON; Pham TH; Bouvier D; Dufau L; Qin L; Reboud-Ravaux M; Ivanov AA; Zhuze AL; Gromova ES; Bouvier-Durand M Biochimie; 2015 Jan; 108():94-100. PubMed ID: 25446655 [TBL] [Abstract][Full Text] [Related]
28. The subunit structure and dynamics of the 20S proteasome in chicken skeletal muscle. Hayter JR; Doherty MK; Whitehead C; McCormack H; Gaskell SJ; Beynon RJ Mol Cell Proteomics; 2005 Sep; 4(9):1370-81. PubMed ID: 15965267 [TBL] [Abstract][Full Text] [Related]
29. Structural organization of the 19S proteasome lid: insights from MS of intact complexes. Sharon M; Taverner T; Ambroggio XI; Deshaies RJ; Robinson CV PLoS Biol; 2006 Aug; 4(8):e267. PubMed ID: 16869714 [TBL] [Abstract][Full Text] [Related]
30. Proteomics analysis reveals a highly heterogeneous proteasome composition and the post-translational regulation of peptidase activity under pathogen signaling in plants. Sun HH; Fukao Y; Ishida S; Yamamoto H; Maekawa S; Fujiwara M; Sato T; Yamaguchi J J Proteome Res; 2013 Nov; 12(11):5084-95. PubMed ID: 23991809 [TBL] [Abstract][Full Text] [Related]
31. Purification of the Arabidopsis 26 S proteasome: biochemical and molecular analyses revealed the presence of multiple isoforms. Yang P; Fu H; Walker J; Papa CM; Smalle J; Ju YM; Vierstra RD J Biol Chem; 2004 Feb; 279(8):6401-13. PubMed ID: 14623884 [TBL] [Abstract][Full Text] [Related]
32. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Wang X; Chen CF; Baker PR; Chen PL; Kaiser P; Huang L Biochemistry; 2007 Mar; 46(11):3553-65. PubMed ID: 17323924 [TBL] [Abstract][Full Text] [Related]
33. Systematic comparison of peptidic proteasome inhibitors highlights the α-ketoamide electrophile as an auspicious reversible lead motif. Stein ML; Cui H; Beck P; Dubiella C; Voss C; Krüger A; Schmidt B; Groll M Angew Chem Int Ed Engl; 2014 Feb; 53(6):1679-83. PubMed ID: 24403024 [TBL] [Abstract][Full Text] [Related]
34. Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome. Keller L; Plaza A; Dubiella C; Groll M; Kaiser M; Müller R J Am Chem Soc; 2015 Jul; 137(25):8121-30. PubMed ID: 26050527 [TBL] [Abstract][Full Text] [Related]
35. New C(4)- and C(1)-derivatives of furo[3,4-c]pyridine-3-ones and related compounds: evidence for site-specific inhibition of the constitutive proteasome and its immunoisoform. Hovhannisyan A; Pham TH; Bouvier D; Piroyan A; Dufau L; Qin L; Cheng Y; Melikyan G; Reboud-Ravaux M; Bouvier-Durand M Bioorg Med Chem Lett; 2014 Mar; 24(6):1571-80. PubMed ID: 24534487 [TBL] [Abstract][Full Text] [Related]
36. Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes. Cornish Carmony K; Sharma LK; Lee DM; Park JE; Lee W; Kim KB Chembiochem; 2015 Jan; 16(2):284-92. PubMed ID: 25477005 [TBL] [Abstract][Full Text] [Related]
37. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes. de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746 [TBL] [Abstract][Full Text] [Related]
38. Using native gel electrophoresis and phosphofluoroimaging to analyze GFP-tagged proteasomes. Enenkel C Methods Mol Biol; 2012; 832():339-48. PubMed ID: 22350896 [TBL] [Abstract][Full Text] [Related]
39. Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides. Zhan W; Singh PK; Ban Y; Qing X; Ah Kioon MD; Fan H; Zhao Q; Wang R; Sukenick G; Salmon J; Warren JD; Ma X; Barrat FJ; Nathan CF; Lin G J Med Chem; 2020 Nov; 63(21):13103-13123. PubMed ID: 33095579 [TBL] [Abstract][Full Text] [Related]